EI- Nile Co. for Pharmaceuticals and Chemical Industries (CASE: NIPH)
Health Care · Pharmaceuticals · EG
EGP332.00
-19.03% today · +617.7% 1Y
EI- Nile Co. for Pharmaceuticals and Chemical Industries (CASE: NIPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $326.27M.
Over the last twelve months the share price has gained 617.7%, trading between 45.60 and 516.96.
Tweenvest scores EI- Nile Co. for Pharmaceuticals and Chemical Industries across four factors: quality 68/100, value 15/100, growth 12/100, dividend 90/100. Its strongest factor is dividend.
NIPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $326.27M
- Revenue (TTM)
- $41.01M
- P/E
- 69.13
- EPS
- 4.80
- Dividend yield
- 0.60%
- Beta (5Y)
- 0.63
- 52-week high
- EGP516.96
- 52-week low
- EGP45.60
- Avg volume (3M)
- —
- Shares outstanding
- 50.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.